Showing results (121-130 of 178) with videos related to
Sort By:
Pageof 18
Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)|May 13, 2011
Prescribing recommendations for the treatment of acute pain in dentistryElliot V Hersh, William T Kane, Michael G O'Neil, et al.Anesthesia Progress|June 13, 2008
Pharmacokinetics of lidocaine with epinephrine following local anesthesia reversal with phentolamine mesylatePaul A Moore, Elliot V Hersh, Athena S Papas, et al.Current Protocols in Immunology|April 16, 2020
Multispecific, Multivalent Antibody-Based Molecules Engineered on the DART® and TRIDENTTM PlatformsLing Huang, Kalpana Shah, Bhaswati Barat, et al.Plos One|February 17, 2021
A humanized CD3ε-knock-in mouse model for pre-clinical testing of anti-human CD3 therapyJoel Crespo, Yi Ting Koh, Ningjie Hu, et al.Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)|March 31, 2015
Use of opioid pain relievers following extraction of third molarsBreanna M Weiland, Anthony G Wach, Brent P Kanar, et al.Ecotoxicology and Environmental Safety|October 24, 2022
Differing behavioral changes in crayfish and bluegill under short- and long-chain PFAS exposures: Field study in Northern Michigan, USACarrie O Coy, Alexandra N Steele, Sara A Abdulelah, et al.Journal of the American Dental Association (1939)|August 3, 2012
The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline: preliminary findingsHelen Giannakopoulos, Lawrence M Levin, Joli C Chou, et al.Journal of the American Dental Association (1939)|August 7, 2008
Reversal of soft-tissue local anesthesia with phentolamine mesylate in adolescents and adultsElliot V Hersh, Paul A Moore, Athena S Papas, et al.Chemotherapy|June 19, 2008
Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virusG Mani Subramanian, Paul A Moore, Brian B Gowen, et al.Endocrinology|September 24, 2005
Osteostat/tumor necrosis factor superfamily 18 inhibits osteoclastogenesis and is selectively expressed by vascular endothelial cellsBernardetta Nardelli, Liubov Zaritskaya, William McAuliffe, et al.Pageof 18